Life Technologies to Buy BioTrove, Which Will Form Mass Spec Sample Prep Company
November 10, 2009
Life Technologies to Buy BioTrove, Which Will Form Mass Spec Sample Prep Company
By a GenomeWeb staff reporter
The deal will expand Life Technologies’ PCR portfolio, while BioTrove will spin out a subsidiary called Biocius Life Sciences for its mass spec sample handling business.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.